Publications scientifiques

2467 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2021

JOURNALRheumatology (Oxford, England)

PREMIER AUTEURGreigert H

TITREHematological Malignancies in Giant Cell Arteritis: a French population-based study.

ANNÉE2021

JOURNALNeuro-oncology practice

PREMIER AUTEURGarnier L

TITREQuality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients.

ANNÉE2021

JOURNALEuropean journal of cancer (Oxford, England : 1990)

PREMIER AUTEURTougeron D

TITRESevere acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER).

ANNÉE2021

JOURNALSurgical innovation

PREMIER AUTEURLi WF

TITRESuper-Selective Intra-Arterial Indocyanine Green Administration for Near-Infrared Fluorescence-Based Positive Staining of Hepatic Segmentation: A Feasibility Study.

ANNÉE2021

JOURNALPharmaceutics

PREMIER AUTEURSabo AN

TITRESirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology.

ANNÉE2021

JOURNALClinics and research in hepatology and gastroenterology

PREMIER AUTEURBlanc JF

TITREHepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI).

ANNÉE2021

JOURNALEuropean journal of cancer (Oxford, England : 1990)

PREMIER AUTEURMansi L

TITREStudy of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients.

ANNÉE2021

JOURNALCurrent opinion in oncology

PREMIER AUTEURPeyrade F

TITRESystemic treatment of metastatic squamous cell carcinoma of the head and neck: proposal for management changes.

ANNÉE2021

JOURNALEuropean journal of haematology

PREMIER AUTEURBouvier A

TITREMolecular classification and prognosis in younger adults with acute myeloid leukemia patients and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: final results of the GOELAMS/FILO AML 2006-IR trial.

ANNÉE2021

JOURNALOncogene

PREMIER AUTEURNehme Z

TITREPolyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus.

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques